# Surgery Partners, Inc. (SGRY) stock: price and valuation

URL: https://funkfolio.com/stock/SGRY

> Surgery Partners, Inc. (SGRY) trades at $26.85, is worth $3.51B and scores 37/100. Valuation history, financials and signals.

---

## Surgery Partners, Inc. (SGRY)

Surgery Partners, Inc. (SGRY) is a healthcare company (medical care facilities) based in the United States. The share price is $26.85, up 0.22% on the day, which values the company at $3.51B. Price as of 17 Nov 2026, 23:25 UTC, from Yahoo Finance.

### Key facts

- **Share price:** $26.85 +0.22% today
- **Market value:** $3.51B
- **Forward P/E:** 134.2×
- **Funk Score:** 37/100
- **Against its own history:** Well above its usual price usual price $20.29
- **200-week average:** $24.92 8% above
- **Sector:** Healthcare

Figures as of 17 Nov 2026, 23:25 UTC. Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

### Surgery Partners, Inc. in more detail

SGRY trades at 134.2× next year's expected earnings, 1.0× sales. Measured against its own history, the price is 32% above what its usual multiples would imply ($20.29) — well above its usual price. It sits 8% above its 200-week average of $24.92.

Over the last five fiscal years Surgery Partners, Inc. has compounded revenue 12.2% a year, free cash flow -0.8% a year. Its Funk Score is 37 out of 100 (financial strength 1.3, profitability 3.5, growth 5.7, value 4.5, each out of 10).

In its favour: Five straight years of revenue growth. Worth checking: Altman Z in the distress zone; Share count keeps rising.

1 of the superinvestors tracked here hold SGRY, including Howard Marks (0.3% of the portfolio).

### Superinvestors holding SGRY

1 of the investors tracked here report a position in their latest 13F filing.

- [Howard Marks Oaktree Capital Management](https://funkfolio.com/gurus/howard-marks) 0.27% of portfolio · $14.5M · new · Q2 2026

### Surgery Partners, Inc. (SGRY): questions and answers

**What is Surgery Partners, Inc.'s market cap?**

Surgery Partners, Inc. is valued at $3.51B at a share price of $26.85.

**Is SGRY overvalued or undervalued?**

Against its own history, SGRY is well above its usual price: the price is 32% above the $20.29 implied by the median multiples it has traded at (price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

**Is SGRY above its 200-week moving average?**

Yes. SGRY is 7.7% above its 200-week average of $24.92. Long-term investors watch that line because strong companies rarely trade below it for long.

**How fast is Surgery Partners, Inc. growing?**

Over the last five fiscal years Surgery Partners, Inc.'s revenue grew 12.2% a year; over ten years revenue grew 13.2% a year.

**Does SGRY pay a dividend?**

Surgery Partners, Inc. does not currently pay a regular dividend.

**Which famous investors own SGRY?**

In their latest quarterly filings, Howard Marks (0.3% of the portfolio) hold SGRY. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

### Learn to read these numbers

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.

### Cite this page

Funkfolio, “Surgery Partners, Inc. (SGRY) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/SGRY

Underlying data: Yahoo Finance; company filings with the SEC.
